Web Analytics

3 Latest Announced Rounds

  • $30,000,000
    Series B

    5 Investors

    Food and Beverage Services
    Nov 19th, 2024
  • $1,200,000
    Seed
    Nanotechnology Research
    Nov 19th, 2024
  • $7,200,000
    Seed

    1 Investors

    Software Development
    Nov 19th, 2024
$1,608.53M Raised in 74 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Rhaeos

start up
United States - Evanston, Illinois
  • 24/12/2021
  • Seed
  • $2,200,000

Rhaeos is a VC backed, clinical stage medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor fluid flow subdermally throughout the body. The company is initially targeting hydrocephalus, a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid (CSF). Implantable shunts, the gold standard treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries. There is no technology available today that can easily assess CSF flow in shunts wirelessly, bedside, and without capital equipment until now.

FlowSense, is a proprietary wireless, wearable, and noninvasive sensor that can be mounted on skin overlying the shunt to detect the presence and magnitude of CSF. Its miniaturized, thin construction is similar in size to a bandage, and it is composed primarily of soft, silicone rubber with no hard edges. Data is wirelessly transmitted to a custom designed mobile app.

Rhaeos received FDA breakthrough designation for FlowSense, is NIH and NSF funded (>$5M), published clinical data in Science and Nature family journals, and is on track for initial market entry in 2022. Follow on products for other chronic conditions are currently in development.

Come join us, we're hiring!


Related People

Anna Lisa SomeraFounder

Anna Lisa Somera United States - Greater Chicago Area

Anna Lisa is serial entrepreneur with deep experience in startups, venture capital, technology transfer, biomedical research, and life science consulting. She specializes in early-stage, cutting edge technology businesses and has been a part of the entrepreneurial community for 18 years.

She helped drive the formation and raised angel and venture funding for several start-up companies while also serving as top management for many of the ventures. She also led regulatory affairs, quality, and operations for several medical device companies. She also has extensive experience in non-dilutive funding having helped new companies receive over $50M in SBIR/STTR, state and private grants. Her experience in this type of funding has landed her several contracts with Argonne National Labs, The Polsky Exchange at the University of Chicago, INVO at Northwestern University, the Illinois University Incubator Network, and more.

She is currently a Co-Founder and Chief Executive Officer of Rhaeos, Inc., a digital health and medical technology company born out of the Rogers Research Group at Northwestern University, developing a non-invasive wearable flow sensors for various chronic medical conditions for hospital and home use. In less than 3 years, she has led the company through multiple value inflection milestones including bringing in >$8M in financing including major NIH and NSF grants, achieving FDA breakthrough designation, collaborating with major hospitals across the country for clinical studies, and winning MedTech Innovator, the largest medical device competition in the world beating out >1000 companies globally.

Anna Lisa has also been published in peer reviewed journals; serves as a Principal Investigator on multiple grants; has three graduate degrees: cell biology, business and public health; and has competed in >100 races including 5 marathons and 2 half-iron man triathlons.